Operating Lease, Right-of-Use Asset in USD of MYRIAD GENETICS INC from Q2 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
MYRIAD GENETICS INC quarterly Operating Lease, Right-of-Use Asset history and change rate from Q2 2019 to Q3 2025.
  • MYRIAD GENETICS INC Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $50.6M, a 11.8% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

MYRIAD GENETICS INC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $50.6M -$6.8M -11.8% 30 Sep 2025 10-Q 04 Nov 2025
Q2 2025 $51.2M -$5.3M -9.38% 30 Jun 2025 10-Q 06 Aug 2025
Q1 2025 $53.4M -$5.5M -9.34% 31 Mar 2025 10-Q 07 May 2025
Q4 2024 $55M -$6.6M -10.7% 31 Dec 2024 10-Q 04 Nov 2025
Q3 2024 $57.4M -$46.6M -44.8% 30 Sep 2024 10-Q 08 Nov 2024
Q2 2024 $56.5M -$50.1M -47% 30 Jun 2024 10-Q 07 Aug 2024
Q1 2024 $58.9M -$48.1M -45% 31 Mar 2024 10-Q 08 May 2024
Q4 2023 $61.6M -$42.3M -40.7% 31 Dec 2023 10-K 28 Feb 2025
Q3 2023 $104M -$6.6M -5.97% 30 Sep 2023 10-Q 07 Nov 2023
Q2 2023 $107M +$23.7M +28.6% 30 Jun 2023 10-Q 04 Aug 2023
Q1 2023 $107M +$36.1M +50.9% 31 Mar 2023 10-Q 04 May 2023
Q4 2022 $104M +$22.1M +27% 31 Dec 2022 10-K 28 Feb 2024
Q3 2022 $111M +$27M +32.3% 30 Sep 2022 10-Q 02 Nov 2022
Q2 2022 $82.9M -$3.7M -4.27% 30 Jun 2022 10-Q 05 Aug 2022
Q1 2022 $70.9M +$12M +20.4% 31 Mar 2022 10-Q 06 May 2022
Q4 2021 $81.8M +$22.1M +37% 31 Dec 2021 10-K 01 Mar 2023
Q3 2021 $83.6M +$20.9M +33.3% 30 Sep 2021 10-Q 04 Nov 2021
Q2 2021 $86.6M +$20.6M +31.2% 30 Jun 2021 10-Q 04 Aug 2021
Q1 2021 $58.9M -$5.6M -8.68% 31 Mar 2021 10-Q 05 May 2021
Q4 2020 $59.7M -$7.6M -11.3% 31 Dec 2020 10-K 25 Feb 2022
Q3 2020 $62.7M -$8.6M -12.1% 30 Sep 2020 10-Q 09 Nov 2020
Q2 2020 $66M +$66M 30 Jun 2020 10-KT 16 Mar 2021
Q1 2020 $64.5M 31 Mar 2020 10-Q 06 May 2020
Q4 2019 $67.3M 31 Dec 2019 10-Q 07 Feb 2020
Q3 2019 $71.3M 30 Sep 2019 10-Q 06 Nov 2019
Q2 2019 $0 30 Jun 2019 10-KT 16 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.